Healthcare - Biotechnology - NASDAQ - GB
$ 3.53
-7.59 %
$ 591 M
Market Cap
-11.77
P/E
INCOME STATEMENT
10 M
REVENUE
-28.4 M
OPERATING INCOME
-29.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Mereo BioPharma Group plc
| Revenue | 10 M |
| Cost Of Revenue | 2.57 M |
| Gross Profit | 7.43 M |
| Operating Expenses | 35.8 M |
| Operating Income | -28.4 M |
| Other Expenses | 1.05 M |
| Net Income | -29.5 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 10.0 | 1.5 | 36.5 | 0.4 | (0.1) | 0 | (3.3) | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 2.6 | 0.9 | 17.9 | 16.3 | 23.6 | 22.7 | 34.6 | 24.6 |
| Gross Profit | 7.4 | 0.6 | 18.6 | (16.0) | (23.7) | (22.7) | (37.9) | (24.6) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 35.8 | 44.5 | 39.5 | 21.2 | 15.9 | 12.5 | 10.7 | 11.6 |
| Selling, General and Administrative Expenses | 18.4 | 19.5 | 15.9 | 21.2 | 15.9 | 12.5 | 10.7 | 11.6 |
| Research and Development Expenses | 17.4 | 25.0 | 23.6 | (16.3) | (23.6) | 22.7 | 34.6 | 24.6 |
| Operating Income | (28.4) | (43.6) | (20.9) | (37.6) | (39.5) | (35.2) | (45.3) | (36.2) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 2.9 | 3.4 | 4.0 | 6.4 | 3.5 | 2.4 | 1.1 | 0.2 |
| Total Other Income | (1.6) | 7.5 | 40.2 | (129.3) | (1.6) | (2.1) | (1.6) | 2.5 |
| Pre-Tax Income | (30.0) | (36.1) | 14.2 | (166.4) | (41.1) | (37.3) | (47.0) | (33.7) |
| NET INCOME | ||||||||
| Tax Provision | (0.5) | (1.9) | 1.5 | (2.8) | (6.3) | (5.3) | (8.2) | (5.3) |
| Net Income | (29.5) | (34.2) | 12.7 | (163.6) | (34.8) | (32.0) | (38.8) | (28.4) |
| EPS | 0.0447 | 0.0567 | 0.0241 | 0.48 | 0.39 | 0.45 | 0.56 | 0.63 |